Stocktoria
BICYCLE THERAPEUTICS PLC BCYC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-05-23
BICYCLE THERAPEUTICS PLC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -340.4% | -595.0% | -704.1% | -806.6% | -561.0% |
| Net margin | -301.7% | -479.2% | -669.7% | -779.3% | -571.2% |
| FCF margin | -347.2% | -470.5% | -235.6% | -726.7% | -143.8% |
| Return on assets | -30.5% | -17.7% | -30.3% | -27.5% | -13.9% |
| Return on equity | -35.9% | -21.3% | -48.7% | -41.6% | -19.3% |
| Debt / equity | — | — | 0.08× | 0.11× | 0.09× |
| Current ratio | 11.98 | 13.81 | 8.08 | 6.92 | 12.65 |
| Revenue growth | 105.8% | 30.8% | 86.5% | 23.6% | 12.6% |
Source: SEC EDGAR filings · CIK 0001761612 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.